Krystal Khoo1, Ryan E K Man2,3, Gwyn Rees4, Preeti Gupta2, Ecosse L Lamoureux5,6,7,8, Eva K Fenwick2,3. 1. Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. 2. Singapore Eye Research Institute (SERI), The Academia, 20 College Road, Level 6, Singapore, 169856, Singapore. 3. Duke-National University of Singapore Medical School, Singapore, Singapore. 4. Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Melbourne, Australia. 5. Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore. ecosse.lamoureux@seri.com.sg. 6. Singapore Eye Research Institute (SERI), The Academia, 20 College Road, Level 6, Singapore, 169856, Singapore. ecosse.lamoureux@seri.com.sg. 7. Duke-National University of Singapore Medical School, Singapore, Singapore. ecosse.lamoureux@seri.com.sg. 8. Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Melbourne, Australia. ecosse.lamoureux@seri.com.sg.
Abstract
IMPORTANCE: Previous work has reported a link between diabetic retinopathy/diabetic macular edema (DR/DME) and psychosocial functioning, although the extent and direction of the association remains uncertain. OBJECTIVE: To determine the relationship between DR/DME and psychosocial functioning, the latter an umbrella term used to capture the emotional and social aspects of functioning which may include, for example, depression; depressive disorder; anxiety; vision-specific distress; diabetes-specific distress and emotional and social well-being. EVIDENCE REVIEW: PubMed, Embase, Medline and the Cochrane Central register were systematically searched for relevant interventional and observational quantitative studies using standardised criteria. Studies with DR/DME and psychosocial functioning as exposures or outcomes were accepted. Study quality was evaluated using the modified Newcastle-Ottawa scale for observational studies, and the modified Down's and Black checklist for interventional studies. FINDINGS: Of 1827 titles initially identified, 42 were included in the systematic review. They comprised of four interventions (one RCT, three non-RCTs) and 38 observational studies (33 cross sectional, five prospective). In studies with DR/DME as the exposure (n = 28), its severity and related vision impairment were consistently associated with poor psychosocial outcomes, mostly higher incidence of depression and depressive symptoms. Baseline depression and depressive symptoms were also associated with greater DR incidence and progression of DR. Medical intervention strategies showed significant improvement in psychosocial outcomes in patients with DR, such as significant improvements in mental health domain scores of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ 25). CONCLUSION AND RELEVANCE: Severity of DR, DME and associated vision loss are significantly associated with poor psychosocial outcomes. Aspects of depression and its symptoms show a bi-directional association, with increased incidence and progression of DR significant in those with baseline depression or depressive symptoms. Based on these findings, we propose two areas that may benefit from targeted interventions: (1) Prevention of development of poor psychological outcomes by preventing and delaying progression of DR/DME; and (2) Improved detection and management of poor psychological functioning by improving screening tools and multidisciplinary care for patients. Subsequent longitudinal studies can further help establish the underlying relationship between the two measures.
IMPORTANCE: Previous work has reported a link between diabetic retinopathy/diabetic macular edema (DR/DME) and psychosocial functioning, although the extent and direction of the association remains uncertain. OBJECTIVE: To determine the relationship between DR/DME and psychosocial functioning, the latter an umbrella term used to capture the emotional and social aspects of functioning which may include, for example, depression; depressive disorder; anxiety; vision-specific distress; diabetes-specific distress and emotional and social well-being. EVIDENCE REVIEW: PubMed, Embase, Medline and the Cochrane Central register were systematically searched for relevant interventional and observational quantitative studies using standardised criteria. Studies with DR/DME and psychosocial functioning as exposures or outcomes were accepted. Study quality was evaluated using the modified Newcastle-Ottawa scale for observational studies, and the modified Down's and Black checklist for interventional studies. FINDINGS: Of 1827 titles initially identified, 42 were included in the systematic review. They comprised of four interventions (one RCT, three non-RCTs) and 38 observational studies (33 cross sectional, five prospective). In studies with DR/DME as the exposure (n = 28), its severity and related vision impairment were consistently associated with poor psychosocial outcomes, mostly higher incidence of depression and depressive symptoms. Baseline depression and depressive symptoms were also associated with greater DR incidence and progression of DR. Medical intervention strategies showed significant improvement in psychosocial outcomes in patients with DR, such as significant improvements in mental health domain scores of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ 25). CONCLUSION AND RELEVANCE: Severity of DR, DME and associated vision loss are significantly associated with poor psychosocial outcomes. Aspects of depression and its symptoms show a bi-directional association, with increased incidence and progression of DR significant in those with baseline depression or depressive symptoms. Based on these findings, we propose two areas that may benefit from targeted interventions: (1) Prevention of development of poor psychological outcomes by preventing and delaying progression of DR/DME; and (2) Improved detection and management of poor psychological functioning by improving screening tools and multidisciplinary care for patients. Subsequent longitudinal studies can further help establish the underlying relationship between the two measures.
Entities:
Keywords:
Depression; Diabetic retinopathy; Psychosocial; Quality of life; Vision impairment
Authors: Ecosse L Lamoureux; E Shyong Tai; Julian Thumboo; Ryo Kawasaki; Seang-Mei Saw; Paul Mitchell; Tien Y Wong Journal: Ophthalmology Date: 2010-02-01 Impact factor: 12.079
Authors: Karin S Coyne; Mary Kay Margolis; Tessa Kennedy-Martin; Timothy M Baker; Ronald Klein; Matthew D Paul; Dennis A Revicki Journal: Fam Pract Date: 2004-08 Impact factor: 2.267
Authors: Louis S Matza; Matthew D Rousculp; Karen Malley; Kristina S Boye; Alan Oglesby Journal: Health Qual Life Outcomes Date: 2008-11-07 Impact factor: 3.186
Authors: Eva K Fenwick; Ryan E K Man; Alfred T L Gan; Amudha Aravindhan; Ching Siong Tey; Hasita Jian Tai Soon; Daniel S W Ting; San I Y Yeo; Shu Yen Lee; Gavin Tan; Tien Y Wong; Ecosse L Lamoureux Journal: Transl Vis Sci Technol Date: 2020-09-30 Impact factor: 3.283
Authors: Lama Assi; Lori Rosman; Fatimah Chamseddine; Perla Ibrahim; Hadi Sabbagh; Nathan Congdon; Jennifer Evans; Jacqueline Ramke; Hannah Kuper; Matthew J Burton; Joshua R Ehrlich; Bonnielin K Swenor Journal: BMJ Open Date: 2020-08-30 Impact factor: 2.692
Authors: Eva K Fenwick; John Barnard; Alfred Gan; Bao Sheng Loe; Jyoti Khadka; Konrad Pesudovs; Ryan Man; Shu Yen Lee; Gavin Tan; Tien Y Wong; Ecosse L Lamoureux Journal: Transl Vis Sci Technol Date: 2020-06-03 Impact factor: 3.283